Arup Dey

Arup Dey

Auto-generated profile, based on publicly available information

Arup Dey

College of Engineering, University of South Florida, Tampa, US

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2020 in JMIR Formative Research
Verified
Journal Article
Open access
ASAvijit Sengupta
Avijit Sengupta
TBTheresa Beckie
Theresa Beckie
KDKaushik Dutta
Kaushik Dutta
ADArup Dey
Arup Dey
SCSriram Chellappan
Sriram Chellappan
Background: Coronary heart disease (CHD) is the leading cause of death and disability among American women. The prevalence of CHD is expected to increase by more than 40% by 2035. In 2015, the estimated cost of caring for patients with CHD was US $182 billion in the United States; hospitalizations accounted for more than half of the costs. Compared with men, women with CHD or those who have undergone coronary revascularization have up to 30% more rehospitalizations within 30 days and up to 1 year. Center-based cardiac rehabilitation is the gold standard of care after an acute coronary event, but few women attend these valuable programs. Effective home-based interventions for improving cardiovascular health among women with CHD are vital for addressing this gap in care. Objective: The ubiquity of mobile phones has made mobile health (mHealth) behavioral interventions a viable option to improve healthy behaviors of both women and men with CHD. First, this study aimed to examine the usability of a prototypic mHealth intervention designed specifically for women with CHD (herein referred to as HerBeat). Second, we examined the influence of HerBeat on selected health behaviors (self-efficacy for diet, exercise, and managing chronic illness) and psychological (perceived stress and depressive symptoms) characteristics of the participants. Methods: Using a single-group, pretest, posttest design, 10 women participated in the 12-week usability study. Participants were provided a smartphone and a smartwatch on which the HerBeat app was installed. Using a web portal dashboard, a health coach monitored participants’ ecological momentary assessment data, their behavioral data, and their heart rate and step count. Participants then completed a 12-week follow-up assessment. Results: All 10 women (age: mean 64.4 years, SD 6.3 years) completed the study. The usability and acceptability of HerBeat were good, with a mean system usability score of 83.60 (SD 16.3). The participants demonstrated statistically significant improvements in waist circumference (P=.048), weight (P=.02), and BMI (P=.01). Furthermore, depressive symptoms, measured with the Patient Health Questionnaire-9, significantly improved from baseline (P=.04). Conclusions: The mHealth prototype was feasible and usable for women with CHD. Participants provided data that were useful for further development of HerBeat. The mHealth intervention is expected to help women with CHD self-manage their health behaviors. A randomized controlled trial is needed to further verify the findings.

1 August 2022 in JMIR Preprints
Verified
Preprint
Open access
TBTheresa Beckie
Theresa Beckie
ASAvijit Sengupta
Avijit Sengupta
ADArup Kanti Dey
Arup Kanti Dey
KDKaushik Dutta
Kaushik Dutta
MJMing Ji
Ming Ji
SCSriram Chellappan
Sriram Chellappan
BACKGROUND Coronary heart disease afflicts 7 million American women annually and is their leading cause of disability globally. Women are undertreated and underrepresented in research; rectifying sex-specific disparities in coronary heart disease outcomes is a national priority. Effective interventions for improving the cardiovascular health behaviors of women are vital for addressing this gap in care. OBJECTIVE In this pilot randomized controlled trial, we aimed to evaluate whether a novel mobile health intervention, HerBeatTM compared to Educational Usual Care, improved exercise capacity at 3 months among women with coronary heart disease. METHODS Women were randomized in a 1:1 ratio to the HerBeatTM group (n=23), a behavior change mobile health intervention with a smartphone, smartwatch, and health coach or to the Educational Usual Care group (n=24) that received a standardized cardiac rehabilitation workbook. Both groups received their usual health care throughout the study. The primary endpoint was exercise capacity measured with the six-minute walk test (6MWT). Secondary outcomes included changes in cardiovascular risk factors, and psychosocial well-being. RESULTS A total of 47 women (age 61.2 ± 9.1 years) underwent randomization. Retention in the study was 89% (42/47) at the 3-month follow-up. The HerBeat™ group improved exercise capacity from baseline to 3 months by 22.1 ± 39.5 meters and the Educational Usual Care group increased by 1.4 ± 46.3 meters on the 6MWT. The between group difference at 3 months of 38 meters (463.7 ± 71.9 meters vs 425.1 ± 92.6 meters) was not statistically significant. The HerBeat™ group significantly improved meters walked from baseline to 3 months (441.6 ± 57.7 meters to 463.7 ± 71.7 meters; P=.016, d=.558) while the Educational Usual Care group did not (423.8 ± 92.6 meters to 425.1 ± 92.6 meters; P=.894, d=-.030). The Educational Usual Care group and HerBeatTM group had similar improvements in secondary outcomes (all P >.05). The mean System Usability score for the HerBeatTM group was 82.0 ± 20.6 indicating that the participants viewed the system favorably. CONCLUSIONS The mobile health intervention led to greater improvements in exercise capacity from baseline to 3 months than the Educational Usual Care intervention. There was no statistically significant difference in exercise capacity between groups. The HerBeatTM intervention was feasible and acceptable with minimal attrition. The results of this trial support the feasibility and acceptability of conducting a large definitive randomized controlled trial. CLINICALTRIAL This study protocol was approved by the University of South Florida Institutional Review Board (PRO # 000400086). Because this study was primarily a pilot feasibility study, our Institutional Review Board did not believe this study was required to be registered at ClinicalTrials.gov. Therefore it was not registered. The reporting of this study was based on CONSORT (Consolidated Standards of Reporting Trials) guidelines.

26 September 2019 in JMIR Preprints
Verified
Preprint
Open access
ASAvijit Sengupta
Avijit Sengupta
TBTheresa Beckie
Theresa Beckie
KDKaushik Dutta
Kaushik Dutta
ADArup Dey
Arup Dey
SCSriram Chellappan
Sriram Chellappan
BACKGROUND Coronary heart disease (CHD) is the leading cause of death and disability among American women. The prevalence of CHD is expected to increase by more than 40% by 2035. In 2015, the estimated cost of caring for patients with CHD was US $182 billion in the United States; hospitalizations accounted for more than half of the costs. Compared with men, women with CHD or those who have undergone coronary revascularization have up to 30% more rehospitalizations within 30 days and up to 1 year. Center-based cardiac rehabilitation is the gold standard of care after an acute coronary event, but few women attend these valuable programs. Effective home-based interventions for improving cardiovascular health among women with CHD are vital for addressing this gap in care. OBJECTIVE The ubiquity of mobile phones has made mobile health (mHealth) behavioral interventions a viable option to improve healthy behaviors of both women and men with CHD. First, this study aimed to examine the usability of a prototypic mHealth intervention designed specifically for women with CHD (herein referred to as HerBeat). Second, we examined the influence of HerBeat on selected health behaviors (self-efficacy for diet, exercise, and managing chronic illness) and psychological (perceived stress and depressive symptoms) characteristics of the participants. METHODS Using a single-group, pretest, posttest design, 10 women participated in the 12-week usability study. Participants were provided a smartphone and a smartwatch on which the HerBeat app was installed. Using a web portal dashboard, a health coach monitored participants’ ecological momentary assessment data, their behavioral data, and their heart rate and step count. Participants then completed a 12-week follow-up assessment. RESULTS All 10 women (age: mean 64.4 years, SD 6.3 years) completed the study. The usability and acceptability of HerBeat were good, with a mean system usability score of 83.60 (SD 16.3). The participants demonstrated statistically significant improvements in waist circumference (P=.048), weight (P=.02), and BMI (P=.01). Furthermore, depressive symptoms, measured with the Patient Health Questionnaire-9, significantly improved from baseline (P=.04). CONCLUSIONS The mHealth prototype was feasible and usable for women with CHD. Participants provided data that were useful for further development of HerBeat. The mHealth intervention is expected to help women with CHD self-manage their health behaviors. A randomized controlled trial is needed to further verify the findings.